ChromaDex Corporation (CDXC) Stock Analysis
DELISTED 2025
What happened to ChromaDex Corporation (CDXC) stock?
ChromaDex Corporation (CDXC) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2025
- Last recorded price (historical):
- $7.87 (last quote on record before the April 2025 delisting; historical, not a current quote)
P/E 39.35 means the share price is 39.35 times one year of earnings per share. Market cap $612M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
ChromaDex Corporation (CDXC). ChromaDex Corporation is a bioscience company focused on healthy aging, researching and commercializing nicotinamide adenine dinucleotide (NAD+) precursors. Their flagship ingredient, NIAGEN, is sold directly to consumers and manufacturers.
Last analyzed: May 10, 2026ChromaDex Corporation (CDXC) Healthcare & Pipeline Overview
More about this archive record
Can I still buy CDXC shares?
No. CDXC stopped trading on public markets in April 2025, so the shares are not available through a broker. Anything you see quoted for CDXC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CDXC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ChromaDex Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.